Vanberra Signal

Evolvere BioSciences

Curated by Signal

Developer of next-generation antibiotics using artificial intelligence models to outpace bacterial resistance

Overview

Developer of next-generation antibiotics using artificial intelligence models to outpace bacterial resistance. The platform combines computational power with biological expertise to design novel protein structures that can evade bacterial resistance and precisely target pathogenic bacteria.

Key facts

Founded
2021

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Provider of software solutions to record TB results in vets

    Health TechnologyFalmouth, United Kingdom
  • Provider of an online community platform for medical education

    Health TechnologyOxford, United Kingdom
  • Provider of a healthcare workforce management software

    Health TechnologyLondon, United Kingdom

About Evolvere BioSciences

What does Evolvere BioSciences do?

Developer of next-generation antibiotics using artificial intelligence models to outpace bacterial resistance.

Where is Evolvere BioSciences headquartered?

Evolvere BioSciences is headquartered in Oxford, United Kingdom.

When was Evolvere BioSciences founded?

Evolvere BioSciences was founded in 2021.

Which sector is Evolvere BioSciences in?

Evolvere BioSciences operates in Health Technology.

Who are Evolvere BioSciences's competitors?

Companies similar to Evolvere BioSciences include Lilac Technology, SmashMedicine, and HealthRota.